Jadee Lee Neff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jadee Lee Neff has a total of 154 co-authors. Here are the top co-authors by number of shared publications:
- Avani A. Pendse
Department of Pathology, Duke University Health System , Durham, NC
2 shared publications - Cindy M. Pabon
Departments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
2 shared publications Inga Sakovich
Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus
2 shared publications- Jacob R. Bledsoe
Department of Pathology, Boston Children’s Hospital, Boston, Massachusetts, USA
2 shared publications - Jake G. Maule
Foundation Medicine, Morrisville, NC, 27560, USA
2 shared publications - Katherine Ismei Zhou
Medical Scientist Training Program, University of Chicago, Chicago, IL 60637, USA
2 shared publications
Latest Publications
- Open Access
- 23 September 2025
- Published by Elsevier in Blood Immunology & Cellular Therapy
- Vol. 1 (3)
Selinexor-based treatments are associated with increased expression of T-cell activation markers in multiple myeloma
- 23 September 2025
- Published by Elsevier in Blood Immunology & Cellular Therapy
- Vol. 1 (3)
Open AccessSelinexor-based treatments are associated with increased expression of T-cell activation markers in multiple myeloma
- Open Access
- 14 April 2025
- Published by Elsevier in Laboratory Investigation
- Vol. 105 (8) , 104174
Clinicopathologic Features and the Spectrum of Myelokathexis in Warts, Hypogammaglobulinemia, Infections, Myelokathexis Syndrome
- 14 April 2025
- Published by Elsevier in Laboratory Investigation
- Vol. 105 (8) , 104174
Open AccessClinicopathologic Features and the Spectrum of Myelokathexis in Warts, Hypogammaglobulinemia, Infections, Myelokathexis Syndrome
- Open Access
Cathepsin Z is a conserved susceptibility factor underlying tuberculosis severity
Tuberculosis (TB) outcomes vary widely, from asymptomatic infection to mortality, yet most animal models do not recapitulate human phenotypic and genotypic variation. The genetically diverse Collaborative Cross mouse panel models distinct facets of TB disease that occur in humans and allows identification of genomic loci underlying clinical outcomes. We previously mapped a TB susceptibility locus on mouse chromosome 2. Here, we identify cathepsin Z ( Ctsz ) as a lead candidate underlying this TB susceptibility and show that Ctsz ablation leads to increased bacterial burden, CXCL1 overproduction, and decreased survival in mice. Ctsz disturbance within murine macrophages enhances production of CXCL1, a known biomarker of TB severity. From a Ugandan household contact study, we identify significant associations between CTSZ variants and TB disease severity. Finally, we examine patient-derived TB granulomas and report CTSZ localization within granuloma-associated macrophages, placing human CTSZ at the host-pathogen interface. These findings implicate a conserved CTSZ-CXCL1 axis in humans and genetically diverse mice that mediates TB disease severity.
Open AccessCathepsin Z is a conserved susceptibility factor underlying tuberculosis severity
Tuberculosis (TB) outcomes vary widely, from asymptomatic infection to mortality, yet most animal models do not recapitulate human phenotypic and genotypic variation. The genetically diverse Collaborative Cross mouse panel models distinct facets of TB disease that occur in humans and allows identification of genomic loci underlying clinical outcomes. We previously mapped a TB susceptibility locus on mouse chromosome 2. Here, we identify cathepsin Z ( Ctsz ) as a lead candidate underlying this TB susceptibility and show that Ctsz ablation leads to increased bacterial burden, CXCL1 overproduction, and decreased survival in mice. Ctsz disturbance within murine macrophages enhances production of CXCL1, a known biomarker of TB severity. From a Ugandan household contact study, we identify significant associations between CTSZ variants and TB disease severity. Finally, we examine patient-derived TB granulomas and report CTSZ localization within granuloma-associated macrophages, placing human CTSZ at the host-pathogen interface. These findings implicate a conserved CTSZ-CXCL1 axis in humans and genetically diverse mice that mediates TB disease severity.
- Open Access
- 26 November 2024
- Published by Springer Nature in Blood Cancer Journal
- Vol. 14 (1) , 1-4
Indolent nodal T follicular helper cell lymphomas—A case series
- 26 November 2024
- Published by Springer Nature in Blood Cancer Journal
- Vol. 14 (1) , 1-4
Open AccessIndolent nodal T follicular helper cell lymphomas—A case series
- Open Access
- 12 July 2024
- Published by American Society of Hematology in Blood Advances
- Vol. 8 (14) , 3754-3759
A novel transmembrane CXCR4 variant that expands the WHIM genotype-phenotype paradigm
Key Points. CXCR4D84H is a novel transmembrane variant outside C-terminus identified in 4 unrelated patients with variable WHIM-like phenotypesCXCR4D84H sh Key Points. CXCR4D84H is a novel transmembrane variant outside C-terminus identified in 4 unrelated patients with variable WHIM-like phenotypesCXCR4D84H sh
- 12 July 2024
- Published by American Society of Hematology in Blood Advances
- Vol. 8 (14) , 3754-3759
Open AccessA novel transmembrane CXCR4 variant that expands the WHIM genotype-phenotype paradigm
Key Points. CXCR4D84H is a novel transmembrane variant outside C-terminus identified in 4 unrelated patients with variable WHIM-like phenotypesCXCR4D84H sh Key Points. CXCR4D84H is a novel transmembrane variant outside C-terminus identified in 4 unrelated patients with variable WHIM-like phenotypesCXCR4D84H sh
- Top Cited Papers
- 21 June 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6702) , 1317-+
Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
The molecular mechanisms that regulate breast cancer cell (BCC) metastasis and proliferation within the leptomeninges (LM) are poorly understood, which limits the development of effective therapies. In this work, we show that BCCs in mice can invade the LM by abluminal migration along blood vessels that connect vertebral or calvarial bone marrow and meninges, bypassing the blood-brain barrier. This process is dependent on BCC engagement with vascular basement membrane laminin through expression of the neuronal pathfinding molecule integrin α6. Once in the LM, BCCs colocalize with perivascular meningeal macrophages and induce their expression of the prosurvival neurotrophin glial-derived neurotrophic factor (GDNF). Intrathecal GDNF blockade, macrophage-specific GDNF ablation, or deletion of the GDNF receptor neural cell adhesion molecule (NCAM) from BCCs inhibits breast cancer growth within the LM. These data suggest integrin α6 and the GDNF signaling axis as new therapeutic targets against breast cancer LM metastasis.
- 21 June 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6702) , 1317-+
Top Cited PapersBreast cancer exploits neural signaling pathways for bone-to-meninges metastasis
The molecular mechanisms that regulate breast cancer cell (BCC) metastasis and proliferation within the leptomeninges (LM) are poorly understood, which limits the development of effective therapies. In this work, we show that BCCs in mice can invade the LM by abluminal migration along blood vessels that connect vertebral or calvarial bone marrow and meninges, bypassing the blood-brain barrier. This process is dependent on BCC engagement with vascular basement membrane laminin through expression of the neuronal pathfinding molecule integrin α6. Once in the LM, BCCs colocalize with perivascular meningeal macrophages and induce their expression of the prosurvival neurotrophin glial-derived neurotrophic factor (GDNF). Intrathecal GDNF blockade, macrophage-specific GDNF ablation, or deletion of the GDNF receptor neural cell adhesion molecule (NCAM) from BCCs inhibits breast cancer growth within the LM. These data suggest integrin α6 and the GDNF signaling axis as new therapeutic targets against breast cancer LM metastasis.
- 17 May 2023
- Published by BMJ in BMJ Case Reports
- Vol. 16 (5) , e252739
Dasatinib-associated follicular lymphoma in a patient with B-cell acute lymphoblastic leukaemia
The tyrosine kinase inhibitor dasatinib is approved for the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukaemia (ALL). Patients on dasatinib can rarely develop a form of benign reversible reactive lymphadenopathy termed follicular lymphoid hyperplasia (FLH). Here, we describe a patient with Ph+ ALL who developed follicular lymphoma (FL) after prolonged treatment with dasatinib and who had complete remission of FL after discontinuation of dasatinib. This case suggests that dasatinib-associated FLH could be a premalignant condition that can transform into FL. Moreover, withdrawal of dasatinib may be sufficient for remission of dasatinib-associated FL.
- 17 May 2023
- Published by BMJ in BMJ Case Reports
- Vol. 16 (5) , e252739
Dasatinib-associated follicular lymphoma in a patient with B-cell acute lymphoblastic leukaemia
The tyrosine kinase inhibitor dasatinib is approved for the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukaemia (ALL). Patients on dasatinib can rarely develop a form of benign reversible reactive lymphadenopathy termed follicular lymphoid hyperplasia (FLH). Here, we describe a patient with Ph+ ALL who developed follicular lymphoma (FL) after prolonged treatment with dasatinib and who had complete remission of FL after discontinuation of dasatinib. This case suggests that dasatinib-associated FLH could be a premalignant condition that can transform into FL. Moreover, withdrawal of dasatinib may be sufficient for remission of dasatinib-associated FL.
- Open Access
- 19 August 2022
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 1 (8) , e0000078
A multiple instance learning approach for detecting COVID-19 in peripheral blood smears
A wide variety of diseases are commonly diagnosed via the visual examination of cell morphology within a peripheral blood smear. For certain diseases, such as COVID-19, morphological impact across the multitude of blood cell types is still poorly understood. In this paper, we present a multiple instance learning-based approach to aggregate high-resolution morphological information across many blood cells and cell types to automatically diagnose disease at a per-patient level. We integrated image and diagnostic information from across 236 patients to demonstrate not only that there is a significant link between blood and a patient’s COVID-19 infection status, but also that novel machine learning approaches offer a powerful and scalable means to analyze peripheral blood smears. Our results both backup and enhance hematological findings relating blood cell morphology to COVID-19, and offer a high diagnostic efficacy; with a 79% accuracy and a ROC-AUC of 0.90.
- 19 August 2022
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 1 (8) , e0000078
Open AccessA multiple instance learning approach for detecting COVID-19 in peripheral blood smears
A wide variety of diseases are commonly diagnosed via the visual examination of cell morphology within a peripheral blood smear. For certain diseases, such as COVID-19, morphological impact across the multitude of blood cell types is still poorly understood. In this paper, we present a multiple instance learning-based approach to aggregate high-resolution morphological information across many blood cells and cell types to automatically diagnose disease at a per-patient level. We integrated image and diagnostic information from across 236 patients to demonstrate not only that there is a significant link between blood and a patient’s COVID-19 infection status, but also that novel machine learning approaches offer a powerful and scalable means to analyze peripheral blood smears. Our results both backup and enhance hematological findings relating blood cell morphology to COVID-19, and offer a high diagnostic efficacy; with a 79% accuracy and a ROC-AUC of 0.90.
- 12 August 2021
- Published by Elsevier in Human Pathology
- Vol. 117, 1-8
Plasma cells are essentially absent in the luminal gastrointestinal tract of patients with “complete” 22q11.2 deletion syndrome (DiGeorge syndrome)
- 12 August 2021
- Published by Elsevier in Human Pathology
- Vol. 117, 1-8
Plasma cells are essentially absent in the luminal gastrointestinal tract of patients with “complete” 22q11.2 deletion syndrome (DiGeorge syndrome)